Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: A systemic review and meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 7, 2014, Pages 3021-3027

  Wu, Dan Dan ^a   Zhang, Ji Xiang ^a   Li, Jiao ^a   Dong, Wei Guo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Duodenal ulcer; Gastric cancer; Gastric ulcer; MDR1; Meta analysis; Peptic ulcer; Polymorphism

Indexed keywords

ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

BIOSYNTHESIS; CARCINOGENESIS; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; META ANALYSIS; PATHOGENICITY; PEPTIC ULCER; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

CARCINOGENESIS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; P-GLYCOPROTEIN; P-GLYCOPROTEINS; PEPTIC ULCER; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 84900865302     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.7.3021     Document Type: Article

References (34)

1. Annese V, Valvano MR, Palmieri O, et al (2006). Multidrug resistance 1 gene in inflammatory bowel disease: a metaanalysis. World J Gastroenterol, 12, 3636-44.
2. Basiri Z, Safaralizadeh R, Bonyadi MJ, et al (2014). Helicobacter pylori vacA d1 genotype predicts risk of gastric adenocarcinoma and peptic ulcers in Northwestern Iran. Asian Pac J Cancer Prev, 15, 1575-9.
3. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
4. Breier A, Barancik M, Sulova Z, et al (2005). P-glycoproteinimplications of metabolism of neoplastic cells and cancer therapy. Curr Cancer Drug Targets, 5, 457-68.
5. Chang H, Rha SY, Jeung HC, et al (2010). Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxelbased chemotherapy. Oncol Rep, 23, 271-8.
6. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
7. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
8. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
9. Ho GT, Moodie FM, Satsangi J (2003). Multidrug resistance 1 gene (p-glycoprotein 170): an important determinant in gastrointestinal disease?. Gut, 52, 759-66.
10. Hoffmeyer S, Burk O, von Richter O, et al (2000). Functional polymorphisms of the human multidrug resistance gene multiple sequence variations and correlation of one allele with p-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 97, 3473-8.
11. Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90.
12. Johnstone RW, Ruefli AA, Smyth MJ (2000). Multiple physiological functions for multidrug transporter P-glycoprotein?. Trends Biochem Sci, 25, 1-6.
13. Larsen UL, Hyldahl OL, Olesen L, et al (2007). Human intestinal P-glycoprotein activity estimated by the model substrate digoxin. Scand J Clin Lab Invest, 67, 123-34.
14. Lauren P (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand, 64, 31-49.
15. Li X, Qu L, Zhong Y, et al (2013). Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. J Cancer Res Clin Oncol, 139, 1433-47.
16. Liu Y, Li L, Qi H, et al (2013). Survivin 231G.C polymorphism and gastrointestinal tract cancer risk: a meta-analysis. PLoS One, 8, 54081.
17. Lozano R, Naghavi M, Foreman K, et al (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-128.
18. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
19. Markova S, Nakamura T, Sakaeda T, et al (2006). Genotypedependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation. Drug Metab Pharmacokinet, 21, 194-200.
20. Mizutani T, Masuda M, Nakai E, et al (2008). Genuine functions of P-glycoprotein (ABCB1). Curr Drug Metab, 9, 167-74.
21. Oliveira J, Felipe AV, Chang PY, et al (2012). Association between the C3435T single-nucleotide polymorphism of multidrug resistance 1 gene and risk of gastric cancer. Mol Med Rep, 6, 395-8.
22. Piao Y, Liu Z, Ding Z, et al (2013). EGF +61A>G polymorphism and gastrointestinal cancer risk: A HuGE review and metaanalysis. Gene, 519, 26-33.
23. Sabahi Z, Salek R, Heravi RE, et al (2010). Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer, 47, 317-21.
24. Song B, Duan ZY, Zhong YH, et al (2013). Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk. Asian Pac J Cancer Prev, 14, 6649-51.
25. Sugimoto M, Furuta T, Shirai N, et al (2008). MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. Life Sci, 83, 301-4.
26. Sung JJ, Kuipers EJ, El-Serag HB (2009). Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther, 29, 938-46.
27. Tahara T, Shibata T, Yamashita H, et al (2011). Influence of MDR1 polymorphism on H. pylori-related chronic gastritis. Dig Dis Sci, 56, 103-8.
28. Tahara T, Arisawa T, Shibata T, et al (2007). Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. J Gastroenterol Hepatol, 22, 1678-82.
29. Wang ZM, Wang T, Bian JN (2013). Association between MDR1 C3435T polymorphism and risk of breast cancer. Gene, 532, 94-9.
30. Wu H, Xu C, Chen G, et al (2013). XRCC1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis. J Gastroenterol Hepatol. [Epub ahead of print]
31. Yuan H, Li X, Wu J, et al (2008). Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance. Curr Med Chem, 15, 470-6.
32. Zhang D, Wang C, Zhou Z (2013). Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer. Pak J Med Sci, 29, 1269-74.
33. Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in metaanalysis of genome searches. Genet Epidemiol, 28, 123-37.
34. Zou TH, Wang ZH, Fang JY (2013). Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Tumour Biol, 34, 2441-50.